CCL2 Antibody (C-term) Blocking Peptide

Catalog Number: ABT-BP6699B
Article Name: CCL2 Antibody (C-term) Blocking Peptide
Biozol Catalog Number: ABT-BP6699B
Supplier Catalog Number: BP6699b
Alternative Catalog Number: ABT-BP6699B-500UG
Manufacturer: Abcepta
Category: Proteine/Peptide
Alternative Names: C-C motif chemokine 2, HC11, Monocyte chemoattractant protein 1, Monocyte chemotactic and activating factor, MCAF, Monocyte chemotactic protein 1, MCP-1, Monocyte secretory protein JE, Small-inducible cytokine A2, CCL2, MCP1, SCYA2
Cytokines are a family of secreted proteins involved in immunoregulatory and inflammatory processes. CCL2 is structurally related to the CXC subfamily of cytokines. Members of this subfamily are characterized by two cysteines separated by a single amino acid. This cytokine displays chemotactic activity for monocytes and basophils but not for neutrophils or eosinophils. It has been implicated in the pathogenesis of diseases characterized by monocytic infiltrates, like psoriasis, rheumatoid arthritis and atherosclerosis. It binds to chemokine receptors CCR2 and CCR4.
NCBI: 6347
UniProt: P13500
Form: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Target: The synthetic peptide sequence used to generate the antibody AP6699b was selected from the C-term region of human CCL2. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.